Optic Pathway Giloma and Vision Testing
Optic Pathway Gliomas are often referred to as OPG and may affect those with neurofibromatosis type1 (NF1). In most cases…
Read More
Check out past blogs and news!
Optic Pathway Gliomas are often referred to as OPG and may affect those with neurofibromatosis type1 (NF1). In most cases…
Read More
$25 million has been allocated specifically for the Neurofibromatosis Research Program (NFRP) in the Fiscal Year 2023 Omnibus appropriates bill…
Read More
We’re putting 2020 through 2022 in the review mirror and looking forward to an amazing 2023. Honestly, it’s been a…
Read MoreWalk4NF Columbia Details Get ready for the annual Columbia Walk4NF! Plus, NF Midwest is celebrating over 40 years as a…
Read More
Neurofibromatosis Midwest is very excited to have Sarah Selogic join our team as our Care and Outreach Coordinator. Sarah is…
Read MoreWalk4NF Madison Details Get ready for the annual Madison Walk4NF! Plus, NF Midwest is celebrating over 40 years as a…
Read MoreClassrooms that Care is a service-learning program that teaches students and/or educational staff about neurofibromatosis (NF) and allied disorders through…
Read More
Over 200 agencies and organizations such as The United Way, Community Action, and Goodwill just to name a few have…
Read More
Many have heard the expression “It’s not what you know. It’s who you know.” That rings true when it comes…
Read More
An article by Sharon Reynolds from the National Cancer Institue highlights the importance of people with neurofibromatosis type 1(NF1) to…
Read More
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.
.png)
